Cite
The Use of Consolidative Proton Therapy After First-Line Therapy Among Patients With Hodgkin Lymphoma at Academic and Community Proton Centers.
MLA
Hoppe, B. S., et al. “The Use of Consolidative Proton Therapy After First-Line Therapy Among Patients With Hodgkin Lymphoma at Academic and Community Proton Centers.” International Journal of Radiation Oncology, Biology, Physics, vol. 96, Oct. 2016, p. S39. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2016.06.107.
APA
Hoppe, B. S., Hill-Kayser, C. E., Tseng, Y. D., Flampouri, S., Elmongy, H., Cahlon, O., Mendenhall, N. P., Maity, A., McGee, L. A., & Plastaras, J. P. (2016). The Use of Consolidative Proton Therapy After First-Line Therapy Among Patients With Hodgkin Lymphoma at Academic and Community Proton Centers. International Journal of Radiation Oncology, Biology, Physics, 96, S39. https://doi.org/10.1016/j.ijrobp.2016.06.107
Chicago
Hoppe, B.S., C.E. Hill-Kayser, Y.D. Tseng, S. Flampouri, H. Elmongy, O. Cahlon, N.P. Mendenhall, A. Maity, L.A. McGee, and J.P. Plastaras. 2016. “The Use of Consolidative Proton Therapy After First-Line Therapy Among Patients With Hodgkin Lymphoma at Academic and Community Proton Centers.” International Journal of Radiation Oncology, Biology, Physics 96 (October): S39. doi:10.1016/j.ijrobp.2016.06.107.